- ICH GCP
- US Clinical Trials Registry
- Researchers
- Belgium
- Multiple Myeloma
Medical specialists from Belgium tagged as investigators in clinical trials studying Multiple Myeloma
Total 11 results
-
Dries DeerenSeen in:
- Other, Roeselare, AZ Delta - Campus Wilgenstraat
- Roeselare West-Vlaanderen, Roeselare, AZ Delta
- Roeselare, AZ Delta
Trials:- NCT04797780 (Principal Investigator)
- NCT04404283 (Principal Investigator)
- NCT05556616 (Principal Investigator)
-
Evelyne Willems, MDSeen in:
- Liege, CHU Sart Tilman
- Liège, CHU Liege
- Liège, CHU de Liege
Trials:- NCT03083574 (Sub-Investigator)
- NCT00603330 (Sub-Investigator)
- NCT03852407 (Sub-Investigator)
Conditions:- Refractory Chronic Graft Versus Host Disease (cGVHD);
- Graft-versus-host Disease;
- Poor Graft Function;
- Low Donor T-cell Chimerism;
- Myelodysplastic Syndromes;
- Multiple Myeloma;
- Hodgkin Lymphoma;
- Non Hodgkin Lymphoma;
- Myeloproliferative Disorder;
- Chronic Lymphoid Leukemia;
- Acute Myeloid Leukemia in Remission;
- Myeloproliferative Syndrome;
- Chronic Myeloid Leukemia in Remission;
- Acute Lymphoid Leukemia in Remission
-
Hélène Schoemans, MD PhDSeen in:
- Leuven, UZ Leuven
Trials:- NCT03852407 (Sub-Investigator)
-
Jo CaersSeen in:
- Liege, Centre Hospitalier Universitaire Sart Tilman
Trials:- NCT05556616 (Principal Investigator)
Conditions: -
Julien DepausSeen in:
- Namur, Yvoir, CHU UCL Namur site Godinne
Trials:- NCT05556616 (Principal Investigator)
Conditions: -
Michel DelforgeSeen in:
- Leuven, University Hospitals Leuven
Trials:- NCT05556616 (Principal Investigator)
Conditions: -
Nathalie MeulemanSeen in:
- Anderlecht, Institut Jules Bordet - Investigational Site Number : 0560001
- Brussels, Jules Bordet Institute
Trials:- NCT04458831 (Principal Investigator)
- NCT04379817 (Sub-Investigator)
Conditions: -
Patrick Flamen, MD, PhDSeen in:
- Brussels, Jules Bordet Institute
Trials:- NCT04379817 (Principal Investigator)
Conditions: -
Rik Schots, MD PhDSeen in:
- Brussels, UZ Brussel
Trials:- NCT03852407 (Sub-Investigator)
-
Sophie Servais, MDSeen in:
- Liège, CHU de Liege
Trials:- NCT03852407 (Sub-Investigator)
Clinical Trials on Multiple Myeloma
-
Lawson Health Research InstituteThe Ottawa Hospital; Hamilton Health Sciences Corporation; Dalhousie University; Niagara Health SystemActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma Stage I | Multiple Myeloma Progression | Multiple Myeloma Stage II | Multiple Myeloma Stage IIICanada
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
City of Hope Medical CenterCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States